122 related articles for article (PubMed ID: 30481993)
1. Association between Thioridazine Use and Cancer Risk in Adult Patients with Schizophrenia-A Population-Based Study.
Chang CC; Hsieh MH; Wang JY; Chiu NY; Wang YH; Chiou JY; Huang HH; Ju PC
Psychiatry Investig; 2018 Nov; 15(11):1064-1070. PubMed ID: 30481993
[TBL] [Abstract][Full Text] [Related]
2. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
Crowley TJ; Hydinger-Macdonald M
Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630
[TBL] [Abstract][Full Text] [Related]
3. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
[TBL] [Abstract][Full Text] [Related]
4. Association of Higher Migraine Risk Among Female and Younger Chronic Osteomyelitis Patients: Evidence from a Taiwan Cohort of One Million.
Chen JH; Wu SC; Muo CH; Kao CH; Tseng CH; Tsai CH
Pain Physician; 2018 Mar; 21(2):E149-E156. PubMed ID: 29565957
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune diseases are associated with an increased risk of schizophrenia: A nationwide population-based cohort study.
Wang LY; Chen SF; Chiang JH; Hsu CY; Shen YC
Schizophr Res; 2018 Dec; 202():297-302. PubMed ID: 29925476
[TBL] [Abstract][Full Text] [Related]
6. Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro.
Csonka Á; Spengler G; Martins A; Ocsovszki I; Christensen JB; Hendricks O; Kristiansen JE; Amaral L; Molnar J
In Vivo; 2013; 27(6):815-20. PubMed ID: 24292587
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study.
Yu TM; Chuang YW; Yu MC; Chen CH; Yang CK; Huang ST; Lin CL; Shu KH; Kao CH
Lancet Oncol; 2016 Oct; 17(10):1419-1425. PubMed ID: 27550645
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia.
Georgotas A; Gerbino L; Jordan B; McCarthy M; Gershon S; Kleinberg D; Lautin A; Stanley M; Rotrosen J
Psychopharmacology (Berl); 1981; 73(3):292-4. PubMed ID: 6113618
[TBL] [Abstract][Full Text] [Related]
9. The risks of major osteoporotic fractures in patients with schizophrenia: a population-based 10-year follow-up study.
Tsai KY; Lee CC; Chou YM; Shen SP; Su CY; Wu HC; Huang MW; Shie JP; Chou FH
Schizophr Res; 2014 Nov; 159(2-3):322-8. PubMed ID: 25445622
[TBL] [Abstract][Full Text] [Related]
10. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of lung cancer in patients with eczema: a nationwide cohort study in Taiwan.
Juan CK; Shen JL; Lin CL; Kim KW; Chen WC
J Dtsch Dermatol Ges; 2016 Sep; 14(9):924-31. PubMed ID: 27607037
[TBL] [Abstract][Full Text] [Related]
12. On Sandoz's claim of thioridazine's comparative safety.
Am J Psychiatry; 1983 Dec; 140(12):1645-8. PubMed ID: 6650700
[No Abstract] [Full Text] [Related]
13. Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study.
Fan YC; Hsu JL; Tung HY; Chou CC; Bai CH
Alzheimers Res Ther; 2017 Feb; 9(1):7. PubMed ID: 28162091
[TBL] [Abstract][Full Text] [Related]
14. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
Acta Psychiatr Scand; 1988 Jul; 78(1):49-56. PubMed ID: 2972165
[TBL] [Abstract][Full Text] [Related]
15. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data.
Hennessy S; Bilker WB; Knauss JS; Margolis DJ; Kimmel SE; Reynolds RF; Glasser DB; Morrison MF; Strom BL
BMJ; 2002 Nov; 325(7372):1070. PubMed ID: 12424166
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study.
Liao CH; Chang CS; Wei WC; Chang SN; Liao CC; Lane HY; Sung FC
Schizophr Res; 2011 Mar; 126(1-3):110-6. PubMed ID: 21216567
[TBL] [Abstract][Full Text] [Related]
17. Thioridazine for schizophrenia.
Sultana A; Reilly J; Fenton M
Cochrane Database Syst Rev; 2000; (3):CD001944. PubMed ID: 10908517
[TBL] [Abstract][Full Text] [Related]
18. Clastogenic effect of the psychotropic drug thioridazine on human chromosomes in vivo.
Saxena R; Ahuja YR
Hum Genet; 1982; 62(3):198-200. PubMed ID: 7169210
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort.
Purhonen M; Koponen H; Tiihonen J; Tanskanen A
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1227-31. PubMed ID: 22941581
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan.
Lin CE; Chung CH; Chen LF; Chi MJ
Eur Psychiatry; 2018 Sep; 53():7-16. PubMed ID: 29859379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
